XML 61 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
12 Months Ended
Jul. 31, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of valuation assumption used to determine fair value of stock-based compensation awards
The fair value of these awards was determined using the following inputs:
Year Ended July 31,
202220212020
Risk-free interest rate
1.2% - 1.8%
0.5% - 1.3%
0.8% - 1.9%
Expected volatility
26.0% - 27.0%
25.4% - 26.6%
21.0% - 23.7%
Expected dividend yield1.6 %1.6 %1.6 %
Expected life:
Director grants8 years8 years8 years
Officer grants7 years8 years8 years
Non-officer grants7 years7 years7 years
Schedule of stock option activity
Option activity was as follows:
 OptionsWeighted
Average Exercise
Price
Balance outstanding as of July 31, 20196,531,250 $39.66 
Granted944,094 51.94 
Exercised(845,086)30.35 
Expired/forfeited(96,279)52.72 
Balance outstanding as of July 31, 20206,533,979 42.44 
Granted1,004,631 46.61 
Exercised(1,030,938)36.00 
Expired/forfeited(62,929)49.95 
Balance outstanding as of July 31, 20216,444,743 44.05 
Granted898,726 59.18 
Exercised(365,267)37.02 
Expired/forfeited(51,041)53.15 
Balance outstanding as of July 31, 20226,927,161 $46.32 
Schedule of outstanding and exercisable options
Outstanding and exercisable stock options as of July 31, 2022 were as follows:
Range of Exercise PricesNumber
Outstanding
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
Number
Exercisable
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
$28.00 to $38.99
1,596,910 2.5$33.38 1,596,910 2.5$33.38 
$39.00 to $44.99
1,255,615 3.242.51 1,255,615 3.242.51 
$45.00 to $50.99
1,567,885 6.945.98 960,561 6.145.89 
$51.00 to $56.99
867,614 7.251.82 547,355 7.251.71 
$57.00 and above
1,639,137 7.759.24 757,247 6.259.13 
6,927,161 5.4$46.32 5,117,688 4.4$43.74 
Schedule of status of options that contain vesting provisions
For the year ended July 31, 2022, activity for non-vested stock options that contain vesting provisions was as follows:
OptionsWeighted
Average Grant
Date Fair
Value
Balance outstanding as of beginning of year1,844,890 $10.79 
Granted898,726 14.24 
Vested(893,304)11.15 
Forfeited(40,839)11.88 
Balance outstanding as of end of year1,809,473 $12.31 
Schedule of performance shares activity
The weighted average grant date fair value related to the Company’s performance-based awards was as follows:
Year Ended July 31,
202220212020
Weighted average grant date fair value$59.40 $46.06 $51.61 
Performance-based awards for non-vested activity were as follows:
Performance SharesWeighted
Average Grant
Date Fair
Value
Balance outstanding as of July 31, 2021
200,567 $48.76 
Granted88,400 59.40 
Vested(97,181)51.61 
Forfeited(3,580)53.23 
Balance outstanding as of July 31, 2022
188,206 $52.20